GFACX
Price
$75.90
Change
-$0.11 (-0.14%)
Updated
Oct 9 closing price
Net Assets
343.07B
NWCCX
Price
$46.02
Change
+$0.03 (+0.07%)
Updated
Oct 9 closing price
Net Assets
887.83M
Interact to see
Advertisement

GFACX vs NWCCX

Header iconGFACX vs NWCCX Comparison
Open Charts GFACX vs NWCCXBanner chart's image
American Funds Growth Fund of Amer C
Price$75.90
Change-$0.11 (-0.14%)
VolumeN/A
Net Assets343.07B
Nuveen Winslow Large-Cap Growth ESG C
Price$46.02
Change+$0.03 (+0.07%)
VolumeN/A
Net Assets887.83M
GFACX vs NWCCX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. NWCCX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and NWCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 343B vs. NWCCX (888M). GFACX (0.00) and NWCCX (0.00) have matching dividends . GFACX was incepted earlier than NWCCX: GFACX (25 years) vs NWCCX (16 years). NWCCX (1.83) is less costly to investors than GFACX (1.36). NWCCX is a more actively managed with annual turnover of: 56.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than NWCCX: GFACX (250) vs NWCCX (2500). GFACX annual gain was more profitable for investors over the last year : 11.58 vs. NWCCX (-2.81). GFACX return over 5 years is better than : 32.58 vs. NWCCX (7.23).
GFACXNWCCXGFACX / NWCCX
Total Expense Ratio1.361.6582%
Annual Report Gross Expense Ratio1.361.8374%
Fund Existence25 years16 years-
Gain YTD19.04013.612140%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets343B888M38,626%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.58-2.81-412%
Returns for 3 years70.0653.04132%
Returns for 5 years32.587.23451%
Returns for 10 years84.188.96940%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTBR23.820.73
+3.16%
Lightbridge Corp
TIL20.750.22
+1.07%
Instil Bio
SLXN4.000.02
+0.50%
Silexion Therapeutics Corp
BEKE18.36-0.14
-0.76%
KE Holdings
NCNO25.50-0.60
-2.30%
nCino